PLAAT4 (AA 1-124) antibody (HRP)
Quick Overview for PLAAT4 (AA 1-124) antibody (HRP) (ABIN8022696)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1-124
-
Purpose
- Anti-RARRES3/PLAAT4 Antibody HRP Conjugated
-
Cross-Reactivity (Details)
- No cross-reactivity with other proteins
-
Purification
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human RARRES3/PLAAT4 recombinant protein (Position: M1-K124).
-
Isotype
- IgG
-
-
-
-
Application Notes
- Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4.
-
Storage
- -20 °C
-
Storage Comment
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing.
-
Expiry Date
- 12 months
-
-
- PLAAT4
-
Background
-
Background: Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. These effects are mediated by specific nuclear receptor proteins that are members of the steroid and thyroid hormone receptor superfamily of transcriptional regulators. RARRES1, RARRES2, and RARRES3 are genes whose expression is upregulated by the synthetic retinoid tazarotene. RARRES3 is thought act as a tumor suppressor or growth regulator.
Gene Full Name: phospholipase A and acyltransferase 4
-
Gene ID
- 5920
-
UniProt
- Q9UL19
Target
-